Catalog No.
RHN02401
Species reactivity
Human
Host species
Mouse
Isotype
IgG2a, kappa
Clonality
Monoclonal
Applications
ELISA
Target
Dendritic cell-specific protein CREA7-1, Adhesion molecule interacting with CXADR antigen 1, Junctional adhesion molecule-like, AMICA1, JAML
Concentration
1 mg/ml
Endotoxin level
Please contact with the lab for this information.
Purity
>95% as determined by SDS-PAGE.
Purification
Protein A/G purified from cell culture supernatant.
Accession
Q86YT9
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Clone ID
SAA1859
Note
For research use only.
Ultrastructural evidence for direct projections from the pontine micturition center to glycine-immunoreactive neurons in the sacral dorsal gray commissure in the cat., PMID:11135240
Neutrophil migration across tight junctions is mediated by adhesive interactions between epithelial coxsackie and adenovirus receptor and a junctional adhesion molecule-like protein on neutrophils., PMID:15800062
Molecular insights into γδ T cell costimulation by an anti-JAML antibody., PMID:21220118
cDNA sequence and Fab crystal structure of HL4E10, a hamster IgG lambda light chain antibody stimulatory for γδ T cells., PMID:21629689
Neutrophil-derived JAML inhibits repair of intestinal epithelial injury during acute inflammation., PMID:24621992
Junctional adhesion molecules mediate transendothelial migration of dendritic cell vaccine in cancer immunotherapy., PMID:30055289
Silencing of junctional adhesion molecule-like protein attenuates atherogenesis and enhances plaque stability in ApoE-/- mice., PMID:31101724
Infliximab treatment in pathology-confirmed neurosarcoidosis., PMID:32718952
JAML promotes CD8 and γδ T cell antitumor immunity and is a novel target for cancer immunotherapy., PMID:34427588
JAML immunotherapy targets recently activated tumor-infiltrating CD8+ T cells., PMID:36701231
Targeted activation of junctional adhesion molecule-like protein+ CD8+ T cells enhances immunotherapy in hepatocellular carcinoma., PMID:40353078
For research use only. Not for human or drug use.
